Characteristics of experts
| Participants 33 (brackets contain number of experts who were invited but did not participate; 13) | |
|---|---|
| Professional role* | |
| Clinicians† 15 (3) | Oncologists 3 (1) |
| Surgeons 4 (0) | |
| Breast physicians 1 (2) | |
| Radiologists 2 (0) | |
| Radiation oncologists 2 (0) | |
| Pathologists 3 (0) | |
| Not otherwise specified 0 (1) | |
| Non-clinical researchers 14 (3) | Epidemiologists/biostatisticians 9 (1) |
| Not otherwise specified [NOS] 5 (1) | |
| Administrators/managers | Administrators/ managers 6 (2) |
| Advocacy leaders 6 (7) | Consumers working in advocacy 3 (6) |
| Clinicians/researchers working in advocacy 3 (1) | |
| Public stance on breast screening‡ | |
| Supportive 16 (9) Mostly supportive§ 3 (1) Critical 6 (0) Unknown to researchers 8 (3) | |
*Note that some experts held more than one professional role.
†Most clinicians engaged in research to a greater or lesser extent.
‡We loosely categorised potential interviewees as being ‘supportive’, ‘mostly supportive’ or ‘critical’ about breast screening based on publicly available commentary.
§Broadly supportive of breast screening but with selected concerns about one or more elements of the programme.